BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2596350)

  • 21. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
    Ko HC; Lu RB; Shiah IS; Hwang CC
    Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased plasma MHPG in dexamethasone-resistant depressed patients.
    Jimerson DC; Insel TR; Reus VI; Kopin IJ
    Arch Gen Psychiatry; 1983 Feb; 40(2):173-6. PubMed ID: 6824413
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Erythrocyte membrane transport of tyrosine and tryptophan and plasma level of MHPG in depressive disorders].
    Lançon C; Jeanningros R; Valli M; Bougerol T; Scotto JC; Tissot R
    Encephale; 1990; 16(4):269-74. PubMed ID: 2209480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Free 3-methoxy-4-hydroxyphenylglycol determined in plasma by liquid chromatography with coulometric detection.
    Hariharan M; VanNoord T; Cameron OG; Curtis GC; Ostrow DG
    Clin Chem; 1989 Feb; 35(2):202-5. PubMed ID: 2914362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary MHPG in subgroups of depressed patients and normal controls.
    Beckmann H; Goodwin FK
    Neuropsychobiology; 1980; 6(2):91-100. PubMed ID: 7354911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma MHPG and age in detoxified alcoholics.
    Halbreich U; Castaneda R; Galanter M; Mandola R; Sharpless N
    Biol Psychiatry; 1990 Mar; 27(6):626-30. PubMed ID: 2322622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression.
    Janicak PG; Davis JM; Chan C; Altman E; Hedeker D
    Am J Psychiatry; 1986 Nov; 143(11):1398-402. PubMed ID: 3777227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary 3-methoxy-4-hydroxyphenylglycol (MHPG) excretion in depression.
    Steiner M; Radwan M; Elizur A; Blum I; Atsmon A; Davidson S
    Jpn J Exp Med; 1979 Apr; 49(2):95-9. PubMed ID: 480680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma 3-methoxy-4-hydroxyphenylglycol changes associated with clinical state and schizophrenic subtype.
    Ko GN; Jimerson DC; Wyatt RJ; Bigelow LB
    Arch Gen Psychiatry; 1988 Sep; 45(9):842-6. PubMed ID: 3415425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions.
    Sack DA; James SP; Doran AR; Sherer MA; Linnoila M; Wehr TA
    Arch Gen Psychiatry; 1988 Feb; 45(2):162-6. PubMed ID: 3337614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma 3-methoxy-4-hydroxyphenylglycol in manic psychosis.
    Halaris AE
    Am J Psychiatry; 1978 Apr; 135(4):493-4. PubMed ID: 637151
    [No Abstract]   [Full Text] [Related]  

  • 32. Characteristics of patients with the highest plasma catecholamine metabolite levels.
    Bowers MB; Swigar ME; Hoffman FJ; Goicoechea N
    Am J Psychiatry; 1988 Feb; 145(2):246-8. PubMed ID: 3422545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.
    Scatton B; Loo H; Dennis T; Benkelfat C; Gay C; Poirier-Littre MF
    Psychopharmacology (Berl); 1986; 88(2):220-5. PubMed ID: 3081934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diurnal rhythm of plasma MHPG in endogenous depression.
    Halbreich U; Goldstein S; Sharpless N; Asnis G; Kang BJ; Ryan J
    Psychiatry Res; 1987 Jan; 20(1):79-81. PubMed ID: 3562693
    [No Abstract]   [Full Text] [Related]  

  • 35. State dependence of noradrenergic activity in a rapidly cycling bipolar patient.
    Ostrow D; Halaris A; Dysken M; DeMet E; Harrow M; Davis J
    J Clin Psychiatry; 1984 Jul; 45(7):306-9. PubMed ID: 6539774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MHPG as a predictor of antidepressant response to imipramine and maprotiline.
    Rosenbaum AH; Schatzberg AF; Maruta T; Orsulak PJ; Cole JO; Grab EL; Schildkraut JJ
    Am J Psychiatry; 1980 Sep; 137(9):1090-2. PubMed ID: 7425162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma-free and sulfoconjugated MHPG in major depressive disorders: differences between responders to treatment and nonresponders.
    Mine K; Okada M; Mishima N; Fujiwara M; Nakagawa T
    Biol Psychiatry; 1993 Nov; 34(9):654-60. PubMed ID: 8292695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Plasma levels of MHPG, HVA and total 5-HIAA in depression. Preliminary study].
    Raucoules D; Levy C; Azorin JM; Bruno M; Valli M
    Encephale; 1992; 18(6):611-6. PubMed ID: 1285270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHPG excretion in endogenous depression: relationship to clinical state and the effects of ECT.
    Joseph MH; Risby D; Crow TJ; Deakin JF; Johnstone EC; Lawler P
    Psychopharmacology (Berl); 1985; 87(4):442-8. PubMed ID: 2867575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amitriptyline and nortriptyline plasma levels, urinary 3-methoxy-4-hydroxyphenylglycol and clinical response in depressed women.
    Corona GL; Cucchi ML; Frattini P; Santagostino G; Schinelli S; Comincioli V; Zerbi F; Fenoglio L; Savoldi F
    Neuropsychobiology; 1986; 16(2-3):97-102. PubMed ID: 3587582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.